4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0000899243-20-030416
Director acquired 1,049,055 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GOLDFISCHER CARL Director | 2020-11-02 | Conversion | +9,587 | 9,587 | D | ||
| GOLDFISCHER CARL Director | 2020-11-02 | Conversion | +1,020,036 | 1,020,036 | I | ||
| GOLDFISCHER CARL Director | 2020-11-02 | Conversion | +19,432 | 19,432 | I | ||
| Derivatives | |||||||
| GOLDFISCHER CARL Director | 2020-09-25 | Grant or award · Series D Preferred Stock | +3,688 | $27.11 | $99,982 | 3,688 | D |
| GOLDFISCHER CARL Director | 2020-11-02 | Conversion · Series C-3 Preferred Stock | −392,367 | 0 | I | ||
| GOLDFISCHER CARL Director | 2020-11-02 | Conversion · Series C-3 Preferred Stock | −7,475 | 0 | I | ||
| GOLDFISCHER CARL Director | 2020-11-02 | Conversion · Series D Preferred Stock | −3,688 | 0 | D | ||
Loading xslF345X03/doc4.xml…